Top 50 Biotech Startup Investors in Sweden (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Chalmers Ventures AB
VC Fund
|
26 | Sweden | Pre-Seed, Seed | Software, Biotechnology, Information Technology | $5.8k–$2.3M |
|
Industrifonden
VC Fund
|
17 | Sweden, United States, Denmark | Series A, Seed | Biotechnology, Software, Information Technology | $1.2M–$21M |
|
Almi Invest
VC Fund
|
17 | Sweden, United States, Ukraine | Seed, Venture - Series Unknown | Software, Health Care, Information Technology | $230k–$5M |
|
Sciety
VC Fund
|
14 | Sweden, Ukraine | Seed, Series A, Venture - Series Unknown | Health Care, Biotechnology, Medical | $128k–$6.9M |
|
Navigare Ventures
VC Fund
|
8 | Sweden, Denmark | Seed, Series A, Venture - Series Unknown | Biotechnology, Energy, Manufacturing | $470k–$21M |
|
Novo Holdings
VC Fund
|
6 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $9.9M–$135M |
|
HealthCap
VC Fund
|
5 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $5.7M–$92M |
|
Norrsken VC
VC Fund
|
4 | Sweden, United Kingdom, Germany | Seed, Series A | Software, Food and Beverage, Artificial Intelligence | $700k–$56M |
|
Karolinska
VC Fund
|
4 | Sweden, Denmark, United States | Seed, Series A | Biotechnology, Health Care, Pharmaceutical | $1.3M–$73M |
|
Voima Ventures
VC Fund
|
3 | Finland, Sweden, Norway | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Artificial Intelligence | $464k–$30M |
|
I Love Lund
VC Fund
|
3 | Sweden | Venture - Series Unknown, Pre-Seed, Seed | Biotechnology, Medical, Forestry | $38k–$2.2M |
|
BackingMinds
VC Fund
|
3 | Sweden, Denmark, Finland | Seed, Pre-Seed | Software, SaaS, Energy | $826k–$8.2M |
|
Fåhraeus Startup and Growth
VC Fund
|
3 | Sweden, Denmark, Finland | Seed, Venture - Series Unknown, Series A | Medical, Health Care, Biotechnology | $851k–$7.3M |
|
Crowberry Capital
VC Fund
|
3 | Iceland, Denmark, Finland | Seed, Series A, Pre-Seed | Software, Gaming, Health Care | $400k–$17M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
3 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.8M–$50M |
|
EIR Ventures
VC Fund
|
3 | Denmark, Sweden, United States | Series A, Seed | Biotechnology, Health Care, Therapeutics | $20M–$73M |
|
Partnerinvest Norr
VC Fund
|
3 | Sweden, United States | Seed, Venture - Series Unknown | Software, Manufacturing, Information Technology | $588k–$6.1M |
|
Inventure
VC Fund
|
3 | Finland, Sweden, United States | Seed, Series A, Series B | Software, Information Technology, Health Care | $549k–$25M |
|
Life Science Invest
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Medical, Biotechnology, Biopharma | $310k–$4.6M |
|
Bånt AB
VC Fund
|
2 | Sweden | Seed | Biotechnology, Manufacturing, Food Processing | |
|
Flerie Invest
VC Fund
|
2 | Sweden, United States, United Kingdom | Series A, Venture - Series Unknown, Series B | Biotechnology, Health Care, Pharmaceutical | $2.5M–$75M |
|
Segulah Medical Acceleration
VC Fund
|
2 | Sweden, United Kingdom, Germany | Series D, Series A, Series B | Health Care, Medical Device, Medical | $8.5M–$245M |
|
Colibri Ventures
VC Fund
|
2 | Sweden, Mexico | Seed, Series A, Venture - Series Unknown | Gaming, Finance, Wellness | $6M–$6M |
|
LU Holding
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Biotechnology, Software, Medical Device | |
|
Nina Capital
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $529k–$21M |
|
ARCH Venture Partners
VC Fund
|
2 | United States, China, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $10M–$250M |
|
Länsförsäkringar
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Real Estate, Biotechnology, Manufacturing | $484k–$1.3M |
|
Andreas Ehn
Angel
|
2 | Sweden, United States, Germany | Seed, Angel, Pre-Seed | Software, Internet, Financial Services | $911k–$7.7M |
|
Imprimatur Capital Fund Management
VC Fund
|
2 | Latvia, United States, United Kingdom | Seed, Debt Financing | Software, Information Technology, Apps | $63k–$549k |
|
LIU Invest
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Biotechnology, Information Technology, AgTech | $88k–$1.4M |
|
Nordic Science Investments
VC Fund
|
2 | Finland, Sweden, United States | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Diagnostics | $373k–$4.6M |
|
Hadean Ventures
VC Fund
|
2 | Norway, Sweden, Austria | Series A, Series B | Biotechnology, Health Care, Medical | $4.3M–$79M |
|
Jens von Bahr
Angel
|
2 | Sweden | Seed, Series A | Health Care, Biotechnology, Art | |
|
FBG Invest
VC Fund
|
2 | Sweden | Seed | Biotechnology, Manufacturing, Food Processing | |
|
SEB Venture Capital
VC Fund
|
2 | Sweden, Denmark, United Kingdom | Series A, Series B | Software, Information Technology, FinTech | $1.2M–$23M |
|
Faro Capital
VC Fund
|
2 | Sweden, United States | Series A, Seed, Venture - Series Unknown | Biotechnology, Gaming, Medical | $2.8M–$25M |
|
Noaber
VC Fund
|
2 | The Netherlands, Israel, Germany | Seed, Series A | Health Care, Medical, Fitness | $423k–$20M |
|
RV Invest
VC Fund
|
1 | United States | Series A | Health Care, Therapeutics, Biotechnology | |
|
Teknoinvest
VC Fund
|
1 | Sweden, Norway, United States | Series B, Series A | Health Care, Biotechnology, Medical | |
|
Fibonacci Growth Capital
VC Fund
|
1 | Sweden | Seed | Biotechnology, Manufacturing, Medical Device | |
|
Bertebos Foundation
VC Fund
|
1 | Sweden | Biotechnology, Manufacturing, Food Processing | ||
|
Scientifica Venture Capital
VC Fund
|
1 | Italy, Sweden, Finland | Seed, Pre-Seed | Biotechnology, Sustainability, Product Research | |
|
Erik Byrenius
Angel
|
1 | Sweden, United States, Belgium | Seed, Pre-Seed, Angel | Health Care, Security, Software | $233k–$2.1M |
|
Per Båtelson
Angel
|
1 | Sweden, United States | Seed, Angel | Health Care, Medical, Medical Device | $1.4M–$4M |
|
Sofinnova Partners
VC Fund
|
1 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6.6M–$109M |
|
Hans and Barbara Bergström
VC Fund
|
1 | Sweden | Venture - Series Unknown | Biotechnology, Medical Device | |
|
Plantbase Foundation
VC Fund
|
1 | Sweden | Biotechnology, Manufacturing, Food Processing | ||
|
Forbion Capital Partners
VC Fund
|
1 | United States, United Kingdom, The Netherlands | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $16M–$180M |
|
Hampus Jakobsson
Angel
|
1 | Sweden, Denmark, United States | Seed, Angel, Series A | Health Care, Software, Artificial Intelligence | $96k–$30M |
|
Idinvest Partners
VC Fund
|
1 | France, United States, Spain | Series B, Series A | Biotechnology, Health Care, Software | $3.3M–$66M |
| Access all 380 investors in Sweden Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
We are a leading tech investor & venture builder in the Nordics. Taking deep tech from lab to market.WELCOMEINVESTMENTS
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Pre-Seed, Seed
- Geography: Sweden
Investor stats
- Total investments: 249
- Round size: Seed $285k–$2.3M; Pre-Seed $5.8k–$318k
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
- Anferra — Turning hazardous steel waste into clean water and green energy.
- InfiniNode Technologies AB — InfiniNode is a semiconductor IP company that seeks to enable efficient data movement in future compute systems.
Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.
Show more...Investment focus
- Industry: Biotechnology, Software, Information Technology
- Stage:Series A, Seed
- Geography: Sweden, United States, Denmark
Investor stats
- Total investments: 197
- Round size: Seed $1.2M–$6.2M; Series A $3.3M–$21M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- Yangi — Yangi is a provider of environmentally friendly packaging solutions.
- Fyndiq — Fyndiq is an e-commerce platform through which we offer a range of products for bargain hungry shoppers. We provide a sales channel for all types of e-tailers who want to boost their sales in an accessible way. Through Fyndiq individual retailers can effect fully sell of its overstock, while consumers have a one stop shop for bargain productsonline. Fyndiq offers more then 220 000 products to consumers from over 1 100 merchants in Sweden. Fyndiq was founded in Stockholm in August 2009 and launched its platform in august 2010. Since then we have been growing rapidly both in terms of turnover and employees. In 2012 our sales was 56 million SEK, a number we doubled in 2013 to sales of almost 124million SEK. In November 2014 Fyndiq raises $20M to take the platform internationally. The funding is notable in that it was led by one of the more prominent VCs based in the Nordics, Northzone, which was an early investor in Spotify. The other investor in this round, Industrifonden, is a VC backed by the Swedish government that invests in startups from the country to help scale them internationally. Currently we are 75 dedicated and motivated team members who make it all happen.
- Avtal24 — Avtal24 offers in an easily accessible manner agreements for both private individuals and companies. They believe in making the law available to everyone and they want everyone to have access to legal security. With us, you write agreements online or together with a lawyer by phone. Always at a fixed price. With high legal expertise, innovativetechnology and great focus on customer benefit and offer the market's most accessible legal services.Avtal24 was founded in 2004 and is headquartered in Stockholm, Sweden.
Almi Invest is Sweden’s most active early-stage venture capital firm, investing in scalable startups across Sustainability, Industry, Tech, and Life Science.We invest from pre-seed to Series A, always co-investing with independent private investors to accelerate innovation and long-term success. Our portfolio spans sustainable solutions,industrial innovation, deep tech, SaaS, and life science, supporting startups that drive economic and environmental progress.With €430 million under management and over 1,000 investments since 2009, we have backed leading companies like MIPS, Tobii, and Neo4j, with notable exits to Google, Apple, Microsoft, and Qlik.Beyond capital, we offer engaged ownership, providing strategic guidance, active board participation, and access to an extensive investor network.Almi Invest is part of the Almi Group and is funded by the European Regional Development Fund, Almi AB, and regional partners.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden, United States, Ukraine
Investor stats
- Total investments: 339
- Round size: Seed $230k–$2.3M; Venture - Series Unknown $561k–$5M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- FirstQFM — FirstQFM is a Stockholm-based quantum technology company building proprietary foundation models for quantum computing.
- Brighteco — Brighteco is an innovative and value-driven Born Circular startup that offers Light as a Service. All Brighteco hardware are build modular and circular from e.g reused computer screens.
- Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
Whether you are an investor or entrepreneur, partner with Sciety to achieve impactful returns and elevate your life science business in the Nordics.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden, Ukraine
Investor stats
- Total investments: 46
- Round size: Seed $128k–$2.3M; Series A $439k–$6.5M; Venture - Series Unknown $1.6M–$6.9M
- Lead/follow: 93% lead, 7% follow
Portfolio highlights
- Capitainer — Capitainer enables patients to collect their own volume-defined dried blood spot at home.Capitainer started in 2016. Their technology is a volumetric blood collection device that enables patients to conveniently and safely collect blood samples in the comfort of their own home, our technology is more accurate than today’s solutions. Capitaineroffers impressive cost and environmental savings for healthcare providers managing millions of conventional blood samples annually.
- Everdrone — Advanced drone operations for public safety and emergency response
- Single Technologies — SINGLE TECHNOLOGIES develops a new type of single-molecule-sensitive 3D sequencing system.They provide single-molecule detection, fiber optics, 3D imaging, genomics, sequencing, and 3-D Seq.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 370
- Round size: Series A $9.9M–$133M; Series B $12M–$135M; Series C $30M–$118M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $165M in 2018
Portfolio highlights
- Tarveda Therapeutics — Developing Pentarins to make a difference in the treatment of patients with solid tumor malignancies
- Tarsa Therapeutics — Tarsa Therapeutics is developing an oral formulation of calcitonin, a peptide hormone for the treatment of osteoporosis that slows the rate of bone destruction.
- Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 133
- Round size: Series A $5.7M–$85M; Series B $12M–$92M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $209M in 2019
Portfolio highlights
- Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
- CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
- Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.
Show more...Investment focus
- Industry: Software, Food and Beverage, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Sweden, United Kingdom, Germany
Investor stats
- Total investments: 108
- Round size: Seed $700k–$14M; Series A $4.2M–$56M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $340M in 2024
Portfolio highlights
- Biorce — Meet the world's first AI clinical trials assistant! We bring innovative technologies to revolutionize healthcare and drug development faster & more efficiently
- Verse — Define & achieve your financial and emissions reduction goals with Aria, a software platform that helps companies buy and manage clean power.
- Endra — Endra is a purpose-built platform for modern MEP engineering. Generate 3D models and drawings, sync with Revit and enjoy coordinated design workflows.
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 32
- Round size: Series A $1.3M–$73M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- BOOST Pharma — Boost Pharma: Developing a stem cell therapy for Osteogenesis Imperfecta.
- Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
- Umecrine Cognition — Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 60
- Round size: Seed $1M–$5.9M; Pre-Seed $464k–$2.1M; Series A $3.9M–$30M
- Lead/follow: 63% lead, 37% follow
Portfolio highlights
- Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
- Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
- Sofi Filtration — Innovation in Industrial Liquid Filtration
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!I Love Lund is a venture capital firm.The firm seeks opportunities to invest in pre-seed rounds
Show more...Investment focus
- Industry: Biotechnology, Medical, Forestry
- Stage:Venture - Series Unknown, Pre-Seed, Seed
- Geography: Sweden
Investor stats
- Total investments: 7
- Round size: Pre-Seed $420k–$456k; Venture - Series Unknown $38k–$2.2M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Cyclicor — Cyclicor is an innovations based company focused on the development and commercialisation of safer and more sustainable polymers. The company was registered in October of 2012 as a spin-off company from the University of Lund in Sweden and began commercial development of its first product Cycli-ClearTM, a bisphenol free polycarbonate, in late 2013.
- Katam Technologies — Katam Technologies helps forestry companies all over the world optimize operations through digitalization, solid data, and planning. With the aid of digitalization, reliable data, and careful planning, Katam assists forestry companies all over the world in maximizing operations. Small businesses and private forest owners can use the Katam app orKatam portal as standalone products to obtain quick and precise measurements.
- Valkyr Defense Systems — Valkyr specializes in cost-effective, modular, and autonomous defense systems, leveraging commercial off-the-shelf (COTS) technology to fast-track production.
We help great minds unleash their full potential!
Show more...Investment focus
- Industry: Software, SaaS, Energy
- Stage:Seed, Pre-Seed
- Geography: Sweden, Denmark, Finland
Investor stats
- Total investments: 35
- Round size: Seed $854k–$3.7M; Pre-Seed $826k–$8.2M
- Lead/follow: 63% lead, 37% follow
- Last fund: Likely still investing — raised $53M in 2022
Portfolio highlights
- Tavion — Critical energy storage infrastructure for a sustainable future.
- Cetasol — Cetasol provides maritime monitoring and analytics software for commercial vessel fleets. Reduce fuel costs, optimize performance, and support regulatory compliance and emissions reporting.
- Helios Innovations — Helios Innovations offers modular evaporation that treats industrial process water on-site. Pay per cubic meter treated. No investment, no complexity.
Fåhraeus Startup and Growth is a venture capital fund that invests early in life science and tech companies.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Sweden, Denmark, Finland
Investor stats
- Total investments: 14
- Round size: Seed $851k–$2.7M; Series A $1.8M–$5.9M; Venture - Series Unknown $1.1M–$7.3M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Aplagon — Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs.
- Fida Biosystems — Quantification and characterisation of complex biology made simple. Study molecular interactions in solution, with only nanoliters of sample. Used by industry leaders.
- Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.
Show more...Investment focus
- Industry: Software, Gaming, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Iceland, Denmark, Finland
Investor stats
- Total investments: 50
- Round size: Seed $1.6M–$4.4M; Pre-Seed $400k–$1.3M; Series A $5.7M–$17M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Quanscient — Quanscient develops multiphysics simulation software utilizing quantum computing algorithms to improve simulation technology. Its Computer Aided Engineering (CAE) platform integrates a unique combination of cloud-native multiphysics solvers, advanced cloud computing, and future quantum integration. The platform also offers engineers over ahundredfold increase in simulation throughput to enable fully digital R&D processes, addressing complex technology challenges in industries like fusion energy, 6G/7G, advanced semiconductors, biomedical, automotive, and aerospace.
- Hemi Health — Hemi Health is a Danish digital-first headache and migraine clinic specializing in diagnosis, personalized treatment, and care for headaches using technology like an app for symptom tracking and video consultations.
- Augmented Hearing — Read more about danish audiology scale-up Augmented Hearing, driving the world's most ambitious audiology solutions and innovations.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 104
- Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
- Rinri Therapeutics — Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.
EIR Ventures is a new Life Science Venture Group in the Nordics.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Seed
- Geography: Denmark, Sweden, United States
Investor stats
- Total investments: 13
- Round size: Series A $20M–$73M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely still investing — raised $143M in 2021
Portfolio highlights
- ArgusEye — ArgusEye is a biotechnology company that provides sensor solutions for real-time detection of biological systems and processes. ArgusEye's patented sensor technology is the result of extensive academic research and is based on nanoplasmonic sensing with fiber optics. By adding customized receptors, ArgusEye can offer flexible and sensitivesensing systems for a variety of targets.
- Moleculent — Moleculent is adding a functional layer of biology to pave the way for unparalleled advancements in biological research.
- Hoba Therapeutics — Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.
Partnerinvest Norr is a private equity firm specialized in software, security, and biometrics sectors. Partnerinvest Övre Norrland AB is a venture capital firms that seeks to invest in limited companies which have are in the expansion phase.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden, United States
Investor stats
- Total investments: 69
- Round size: Seed $588k–$2.1M; Venture - Series Unknown $794k–$6.1M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — last raise in 2009
Portfolio highlights
- Cold River Games — Crystalfall is an upcoming free online action RPG with customizable skills and an endless endgame, set in a steampunk world.
- Original Creation — Original Creation envisions a sustainable future in which capital is focused on long-term benefits for both people and the environment, and resources are properly managed through circular systems."
- Remos Space Systems — Remos Space Systems simplifies satellite ground operations.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 176
- Round size: Seed $549k–$5.9M; Series A $1.3M–$17M; Series B $1.3M–$25M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $169M in 2022
Portfolio highlights
- Leetify — We help gamers identify their weaknesses, work on those weaknesses and track their progression.
- UpCloud — World's fastest cloud servers with a 100% uptime SLA! Sign up for a free trial today.
- ONEiO — ONEiO is a cloud-native integration service provider connecting people, processes, and tools – enabling seamless collaboration without traditional integration hassle. Provided as a turn-key solution, as self-service, or something in between. You choose.
LSI Academy - New education 2026, read more here
Show more...Investment focus
- Industry: Medical, Biotechnology, Biopharma
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 6
- Round size: Seed $682k–$4.6M; Pre-Seed $310k–$500k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Haga Bioscience — Mission Technology Assays Benefits Team Contact us Focus whereit truly matters. In situ RNA detection at single nucleotide resolution, bridging discovery and translation. Our mission Bridging discovery and translation Spatial omics technologies have transformed how we study tissue biology.However, translating these discoveries into robust, actionable biomarkers remains a major bottleneck, limited by a lack of
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
Bånt AB
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Food Processing
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mycorena — Mycorena is a fungi-based, next-generation vegan protein and food manufacturing solution to plants, using significantly less resources. Mycorena was established in 2017 and is headquartered in Gothenburg, Sweden.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: Sweden, United States, United Kingdom
Investor stats
- Total investments: 24
- Round size: Series A $2.5M–$23M; Series B $12M–$75M; Venture - Series Unknown $4.5M–$47M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
- Nanologica — Nanologica combines unique know-how in the field of materials technology with a genuine interest in solving real problems in life science. The company works with nanoporous silica which has properties that are attractive in a wide variety of applications. In order to succeed, development work is carried out in close dialog with customers.Nanologica is unique in that it is a world leader in controlling the form, type of porosity and surface area of particles of silica. This competence can be used to produce particles that have the potential to solve problems in diverse application areas. The company’s core competency has been developed and expanded in twoareas of application in particular: drug delivery on the one hand and on the other chromatography, a technology used for the separation and purification of products on the market and in development.The starting point for Nanologica’s work is the material sciences, a field in which the company’s founder has developed and patented completely new materials. The initial research was based at Stockholm University and the Ångström laboratories atUppsala University.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
Segulah Medical Acceleration is a Scandinavia-based investment company focusing on innovative medical technology companies in Europe.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series D, Series A, Series B
- Geography: Sweden, United Kingdom, Germany
Investor stats
- Total investments: 7
- Round size: Series A $8.5M–$12M; Series D $34M–$245M
- Lead/follow: 71% lead, 29% follow
Portfolio highlights
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative in situ proximity ligation assay-based solutions for spatial proteomics.
- Collective Minds — Collective Minds develops and delivers a cloud-based collaboration platform for healthcare and research with access to data, human and digital expertise.
Colibri Ventures invest in early-stage life science companies and help accelerate their innovations into commercial products.
Show more...Investment focus
- Industry: Gaming, Finance, Wellness
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden, Mexico
Investor stats
- Total investments: 4
- Round size: Seed $6M–$6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mundi — Mundi provides financial, trade development, strategy, freight and reinventing international trade services.
- Mindforce Game Lab — Mindforce Game Lab creates meaningful games with characters that act as companions on the journey to better health.
- Pixelgen Technologies — Understand the role of proteins in cellular organization with spatial proteomics. Get ahead in the field of proteomics with us.
LU Holding is a Lund University’s investment company.
Show more...Investment focus
- Industry: Biotechnology, Software, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- MedVasc — MedVasc has developed Solution a patented medical device that reduces pain when treating varicose veins.
- Bionamic — Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
- Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 95
- Round size: Seed $2M–$6.3M; Pre-Seed $529k–$2.4M; Series A $5M–$21M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Biobase — Biobase is the agentic system for clinical data, closing the gap between clinical data and outcomes.
- Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
- Woodway Assurance — Woodway Assurance provides EviData, an AI-driven software for automated privacy assurance on de-identified and synthetic datasets.
ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, China, United Kingdom
Investor stats
- Total investments: 433
- Round size: Series A $10M–$216M; Series B $14M–$250M; Series C $15M–$167M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Synchron — The endovascular brain computer interface.
- Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
- LifeMine Therapeutics — LifeMine is a clinical-stage biopharmaceutical company pioneering a bold new approach, Top-Down Drug DiscoveryTM, which leverages evolutionary insights from fungi to unearth next-generation precision medicines.
Länsförsäkringar is a Swedish group of public insurance companies.
Show more...Investment focus
- Industry: Real Estate, Biotechnology, Manufacturing
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 12
- Round size: Seed $484k–$1.3M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Stendorren Fastigheter — Stendorren Fastigheter is a company involved in the real estate industry. It develops, owns, operates, and maintains industrial, logistical, and warehouse facilities. The business offers adequate and suitable space on fair lease terms through its tenant.
- pixlbio (formerly Phenaros) — Data-centric drug discovery with AI, Phenomics and Automation.
- Swedish Logistic Property — Swedish Logistic Property (SLP) specializes in the development and management of logistics properties across Sweden. With a focus on energy efficiency, SLP provides modern logistics solutions tailored to meet the needs of various businesses. The company's portfolio includes strategically located properties designed to support efficientlogistics and supply chain operations. SLP also engages in the acquisition and development of new properties, aiming to expand its footprint in the logistics real estate market. The company's commitment to sustainability is evident in its construction practices and the operation of its logistics facilities.
Andreas is working on a service that will connect people, time and places on the web. He also works as an independent consultant helping other startups with product strategy, technical infrastructure, scalability and recruiting as well as financial companies (venture capital and private equity) with technical due diligence and in other advisorroles.He was CTO at Spotify from the launch of the company in August 2006 until November 2009. Before that he worked at Stardoll as an engineer and project manager.
Show more...Investment focus
- Industry: Software, Internet, Financial Services
- Stage:Seed, Angel, Pre-Seed
- Geography: Sweden, United States, Germany
Investor stats
- Total investments: 18
- Round size: Seed $911k–$7.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Visor — Spatial computing designed for work.
- Mavenoid — Mavenoid is the only product support automation platform built for complex products and devices. Using our unique AI, we solve problems too complex for chatbots
- Red Flag — Red Flag develops an automated accounting, expenses, and invoicing platform for SMEs.
Imprimatur Capital Fund Management is a venture capital firm focusing on high-technology at an early stage in its commercial development. We invest in start-up technology businesses which are based on innovative intellectual property, are led by strong teams and have high international growth potential.Imprimatur Capital Fund Management, based inLatvia, manages seed and start-up funds with investors including the Latvian Guarantee Agency, other institutional investors and some private investors. The company source investment opportunities primarily from the Baltic/Nordic/Russia region.Imprimatur Capital Fund Management is a partner firm of Imprimatur Capital Ltd, headquartered in London and with investment operations in Europe, Russia, Asia Pacific, Latin America and the US.
Show more...Investment focus
- Industry: Software, Information Technology, Apps
- Stage:Seed, Debt Financing
- Geography: Latvia, United States, United Kingdom
Investor stats
- Total investments: 81
- Round size: Seed $131k–$549k; Debt Financing $63k–$70k
- Lead/follow: 20% lead, 80% follow
- Last fund: May invest from a new fund soon — last raise in 2010
Portfolio highlights
- Axial3D — Leading the way with the latest 3D imaging, models, and devices
- afriQloud — AfriQloud provides a white-labeled cloud computing solution to telecom operators, internet service providers, system integrators, and managed information technology service providers.
- Sonarworks — SoundID Reference software calibrates your speakers and studio headphones, so you can trust that every mix will translate.
LIU invests in companies that are based on projects and ideas from Linköping University. LIU Invest is focused on investments in early phases. Investments are typically 250 000, but can be doubled by an additional investment.
Show more...Investment focus
- Industry: Biotechnology, Information Technology, AgTech
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 9
- Round size: Seed $579k–$1.4M; Pre-Seed $88k–$282k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.
- Sonicflora — Plants have always been speaking. We can now understand them.
- Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Diagnostics
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 17
- Round size: Seed $373k–$4.6M; Pre-Seed $380k–$837k; Series A $2.9M–$3.9M
- Lead/follow: 88% lead, 12% follow
Portfolio highlights
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- mu-ray.tech — Mu-ray.tech is focused on advancing the field of medical diagnostics and industrial quality control. mu-ray.tech is developing a groundbreaking technology for the rapid, safe and accurate 3D-imaging of the chemical composition of scanned objects, serving critical needs in industrial quality control and medical diagnostics. The technology is basedon Muon Beam Imaging (MBI), an innovative technology leveraging Laser Plasma Accelerator-based artificial muon sources, new generation particle detector systems and AI. In industry, we are working with the partners in the heavy, aerospace, and defence domains.mu-ray.tech operates at the three sites: DESY in Hamburg (hardware), Tehnopol in Tallinn (algorithms and software), and Bradfield Centre in Cambridge (algorithms, business development). Our main collaboration on the MBI technology partners are GScan in Estonia and UK, DESY in Hamburg, the University of Cambridge, and KBFI in Tallinn.
- Perfat Technologies — Perfect fats for better foods.
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Norway, Sweden, Austria
Investor stats
- Total investments: 32
- Round size: Series A $4.3M–$79M; Series B $4.5M–$75M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $105M in 2021
Portfolio highlights
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
- Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Jens von Bahr is the CEO and Co-Founder at Evolution Gaming. Jens von Bahr attended Stockholm University.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Art
- Stage:Seed, Series A
- Geography: Sweden
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Barnebys — Barnebys is the world’s leading search service for art, antiques and collectibles. We were founded in Stockholm, Sweden in 2011 and have since then established our business globally with offices in New York, UK, France, Spain and Germany. Our clients include the world’s top tier of auctioneers, antique dealers, galleries as well as regional andlocal businesses. We are also offering an extensive free database of auction results and a top of the line valuation service. We are now looking to grow our business even further and are seeking top talent to join our team.
- Cellcolabs — Cellcolabs provides high quality stem cells at competitive prices for use within research and treatments.
- Single Technologies — SINGLE TECHNOLOGIES develops a new type of single-molecule-sensitive 3D sequencing system.They provide single-molecule detection, fiber optics, 3D imaging, genomics, sequencing, and 3-D Seq.
FBG Invest
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Food Processing
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mycorena — Mycorena is a fungi-based, next-generation vegan protein and food manufacturing solution to plants, using significantly less resources. Mycorena was established in 2017 and is headquartered in Gothenburg, Sweden.
SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make thefinancial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.
Show more...Investment focus
- Industry: Software, Information Technology, FinTech
- Stage:Series A, Series B
- Geography: Sweden, Denmark, United Kingdom
Investor stats
- Total investments: 72
- Round size: Series A $1.2M–$12M; Series B $2.2M–$23M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $300M in 1995
Portfolio highlights
- Apica — Apica is the agentic-ready telemetry pipeline that cuts observability costs up to 40%. Control your data, eliminate tool sprawl, and scale for AI.
- MobileTag — Mobile Tag, the European leader in mobile barcode solutions, continues to innovate with the launch of its latest application: mobiletag Universal Reader and shopping.Mobile Tag is behind the creation of the flashcode, the standard 2D barcode used by operators in France. This type of Datamatrix barcode is used by the biggest companies indisplay, transportation, distribution, the pharmaceutical industry, and more.Mobile Tag has always tried to develop new technology from the consumer's point of view, and the mobiletag Universal Reader & shopping is no exception.The concept behind this application is to send, receive and share information and best prices to everyone and for everyone through all standardized barcodes.Scanning a barcode with your mobile phone is simply taking a picture of it with your phone, using the mobiletag application. Mobile tag is free!
- CorPower Ocean — CorPower Ocean AB was founded in 2009 to develop high efficiency Wave Energy Converters (WECs).CorPower's Wave Energy Converters deliver five times higher annual energy output per ton of device compared to previously known wave power solutions. The step-change improvement in performance and efficiency allows a Cost-of-Energy that cancompete with offshore wind. The products are currently in pilot with Iberdrola. CorPower has assembled a team with extensive experience in energy generation, design and manufacturing of production equipment, system engineering as well as the market expertise to allow us to continue transforming the technology of tomorrow into renewable energy applications of today.
FARO is an Argentina company over 10 years of experience in the development and operation of integrated projects in the agribusiness sector. All projects FARO own position it as a reference and leader both locally and internationally.Among his various projects, FARO operates the largest tree planting pecan nut Latin America, with projection tobecome the largest southern hemisphere and one of the largest in the world. This project is structured under different vehicles, including Alto Pecan stands, the first real estate development of nautical fields planted with pecan nut Latin America, located in Villa Paranacito, Entre Ríos . Another project is AgroConsortium, productive trust for the production and marketing of cereals and oilseeds in leased farms located in different productive areas in Argentina and potentially in the region. Finally, thanks to the expertise acquired in agribusiness, FARO developed his own business model for productive land conversion. Its aim is to position rural properties whose productive potential is not reflected in the price and complement the cycle with the economic use of land in intensive production, short and medium term.Since 2006, the Investor Group is a strategic partner OMBU FARO for all investment portfolios development ventures related to agribusiness, that focus on supply both local and international markets.
Show more...Investment focus
- Industry: Biotechnology, Gaming, Medical
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Sweden, United States
Investor stats
- Total investments: 5
- Round size: Series A $2.8M–$25M
- Lead/follow: 20% lead, 80% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- Bionamic — Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
- Bluwhale — Unlock Web3 Wallet Potential with AI Insights. Supercharge Your Business Growth
- IntuiCell — IntuiCell develops a fundamentally new recursive computing architecture and associated technology platform.
Noaber Ventures invests in initiatives that bring social transformations using information technology.
Show more...Investment focus
- Industry: Health Care, Medical, Fitness
- Stage:Seed, Series A
- Geography: The Netherlands, Israel, Germany
Investor stats
- Total investments: 20
- Round size: Seed $423k–$6.3M; Series A $3M–$20M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Plasmacure — Plasmacure develops innovative plasma technology for wound care. Discover how cold plasma is transforming the treatment of chronic wounds.
- Mirantus Health — Mirantus is building a distributed healthcare provider to improve access to care for underserved patients. Through healthcare services (Mirantus Care) and cloud-solutions (Mirantus OS), Mirantus empowers doctors to efficiently treat patients who were difficult to reach before. This improves healthcare access for patients, allows physicians to earnmore, while saving payors billions in downstream costs. Mirantus is on a mission to get every specialist physician in Europe to participate in distributed healthcare, to improve healthcare access for 100M+ underserved patients.
- Alba Health — Discover your baby's gut health & microbiome for the best start in life.
RV Invest early and stand alongside founders and researchers to bring outstanding ideas to the market.
Show more...Investment focus
- Industry: Health Care, Therapeutics, Biotechnology
- Stage:Series A
- Geography: United States
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Akribion Genomics — Specific, versatile, effective RNA-guided cell depletion
- Arda Therapeutics — Arda Therapeutics is a biotechnology company taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions. Their approach starts by using single-cell data to identify pathogenic cells and specific markers to target them. They then design therapies to eliminate these - and only these - cells.Arda wasfounded in 2021 in the San Francisco Bay Area, CA.
- Alesta Therapeutics — Alesta Therapeutics pioneers innovative small molecule therapies for rare diseases, including hypophosphatasia and Charcot-Marie-Tooth
Teknoinvest is a premier Scandinavian venture capital company. They invest in areas of emerging technologies within the ITC and Life Sciences sectors. Their main geographical scope is Scandinavia and the USA. Teknoinvest was established as the first venture capital investment company. Teknoinvest is one of the most successful VC´s in Scandinaviaaccording to track record of value created for their investors.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A
- Geography: Sweden, Norway, United States
Investor stats
- Total investments: 23
- Lead/follow: no public data
Portfolio highlights
- GLO — glō is a venture-backed company focused on the development and commercialization of advanced LED display products using nanotechnology. The unique nanotechnology is based on 11 years of research at Lund University’s Nanometer Structure Consortium. Headed by Professor Lars Samuelson, one of the world’s leading scientists in this field, who haspublished more than 500 papers related to this technology.glō's first office is in Lund, Sweden, where basic material research continues for the next generation nanotechnology. glō's research and product development along with pilot fabrication operation is carried out at glō-USA in Sunnyvale, California. In 2016, glō established an Asia office in Taipei, Taiwan, one of the largest and fastest-growing regions for LED lighting and display applications.glō's technology sidesteps the technical limitations of current planar LED technology. It allows for the creation of highly efficient, stable and ultimately unique red, green, blue (RGB) emitters out of one material system. It aims to achieve the industry’s best color stability and ultimately enables the growth of red, green and blue emitters on the same wafer. Highly-efficient white LEDs with high color rendering will be possible without the need for phosphor conversion. It is the next enabling technology for advanced display, illumination and automotive applications.glō nanowire light-emitting diodes (nLEDs) are based on its proprietary hetero-structured semiconductor nanowire epitaxial growth and process technologies for which standard manufacturing equipment and materials can be utilized.glō currently holds over 175 patents across US, Europe and Asia. These patents are not subject to any cross-licensing with the LED oligopoly. The glō team is constantly strengthening its intellectual property position in this technology and related applications.
- SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
- Sol Voltaics — Founded in 2007, Sol Voltaics AB is a venture-backed, development-stage nanotechnology company focused on development and commercialization of highly efficient, third-generation photovoltaic concentrator solar cells based on its proprietary heterostructured nanowire epitaxial growth and process technologies.
Fibonacci Growth Capital is a venture capital investment firm.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Medical Device
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Pixelgen Technologies — Understand the role of proteins in cellular organization with spatial proteomics. Get ahead in the field of proteomics with us.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Bertebos Foundation
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Food Processing
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mycorena — Fungi-based, next-generation vegan protein. A food manufacturing solution superior to plants, using significantly less resources.
Scientifica Venture Capital offers private equity and venture capital investment services for Italy based startups and firms.
Show more...Investment focus
- Industry: Biotechnology, Sustainability, Product Research
- Stage:Seed, Pre-Seed
- Geography: Italy, Sweden, Finland
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- PlantBit — PlantBit is a producer of sensors and services for smart farming.
- LOTO Biotech — LOTO Biotech is a biotechnology platform focused on supporting the development of treatments for rare diseases, particularly those caused by dominant negative genetic mutations.
- LayerLogic AB — Reliable and instantaneous bacteria detection
Erik Byrenius is a founding partner of Mudcake, a microfund run by ex-founders dedicated to making the world a better place for the next generation. We invest in the strongest founders shaping the way we produce, distribute and consume food. Our typical ticket is $200k-$600k in pre-seed and seed rounds globally.Previously he was the CEO andco-founder of food delivery business OnlinePizza (exit to Delivery Hero), founder of StartupTools and co-founded the angel syndicate Nordic Makers.
Show more...Investment focus
- Industry: Health Care, Security, Software
- Stage:Seed, Pre-Seed, Angel
- Geography: Sweden, United States, Belgium
Investor stats
- Total investments: 12
- Round size: Seed $360k–$2.1M; Pre-Seed $233k–$1.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Digitail — Grow your practice, offer a modern client experience, and automate routine practice tasks with the proven all-in-one veterinary software.
- Mavenoid — Mavenoid is the only product support automation platform built for complex products and devices. Using our unique AI, we solve problems too complex for chatbots
- Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
Per Båtelson
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Angel
- Geography: Sweden, United States
Investor stats
- Total investments: 6
- Round size: Seed $1.4M–$4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Valar Labs — AI to Make Oncologists Smarter
- Imaginecare — Imaginecare is a self-care support that helps patients with long-term health challenges to a better life. Imaginecare consists of a technical platform supplemented with a range of services and analysis tools that together offer a complete solution for healthcare.
- Care to Translate — We provide medical translations for healthcare professionals and patients. Available in 40 languages, 24/7 on your smart device or browser.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 329
- Round size: Series A $6.6M–$70M; Series B $10M–$109M; Series C $12M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
- Biosyntia — Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology.By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds byfermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We partner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow.Biosyntia is located at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.
- Comet Biorefining — Comet Biorefining is a leading provider of sustainable high-quality cost-competitive cellulosic glucose technology for applications in renewable biofuels and biochemicals. The company’s proprietary technology allows for the conversion of wood, wheat straw, bagasse, corn stover and other agricultural waste materials into high purity cellulosicglucose syrup. These non-food sources offer lower cost and price stability when compared to food sugar sources such as corn or sugar cane. Demonstrated at 5 dry tons per day scale, Comet is focusing on commercial scale up and development of commercial partnerships with applications in renewables industries.
Hans and Barbara Bergström is a family investment office.
Show more...Investment focus
- Industry: Biotechnology, Medical Device
- Stage:Venture - Series Unknown
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Sigrid Therapeutics — Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics.
Plantbase Foundation
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Food Processing
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mycorena — Mycorena is a fungi-based, next-generation vegan protein and food manufacturing solution to plants, using significantly less resources. Mycorena was established in 2017 and is headquartered in Gothenburg, Sweden.
Impacting the future of medicine.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 208
- Round size: Series A $19M–$180M; Series B $16M–$155M; Series C $19M–$120M
- Lead/follow: 52% lead, 48% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
- Inflazome — Situs gacor premium Megawin188 paling banyak di minati oleh semua kalangan karena pecah selayar tanpa henti dan memiliki tampilan yang sangat memanjakan mata.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Hampus Jakobsson is a General Partner at early stage climate tech venture fund Pale Blue Dot.Prior to co-founding Pale Blue Dot, Hampus was a Venture Partner at science fund Blue Yard and a prolific angel investor with >100 angel investments. He co-founded of The Astonishing Tribe (acquired by Blackberry in 2010 for $150m). He left Blackberry2012 to found Brisk.io a sales productivity tool which folded 2016.
Show more...Investment focus
- Industry: Health Care, Software, Artificial Intelligence
- Stage:Seed, Angel, Series A
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 43
- Round size: Seed $310k–$5.3M; Angel $96k–$1.2M; Series A $2.3M–$30M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- ClimateView — ClimateView is a Swedish climate action technology company that helps cities transform climate planning into progress. We combine data, agent-based modelling and interface design to help cities successfully manage the transition to zero carbon economies.
- Mojo — Clinical-grade, AI-powered sperm analysis from the comfort of home. Test your sperm count, motility, morphology and much more with the Mojo kit. Check your fertility from home at low cost - without the need for clinic visits and awkward waiting rooms.
- Volta Greentech — Discover innovative solutions to reduce agricultural emissions with Volta Greentech's science-driven feed additives, promoting sustainable farming and planetary health.
Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series B, Series A
- Geography: France, United States, Spain
Investor stats
- Total investments: 254
- Round size: Series A $3.3M–$27M; Series B $7.8M–$66M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $88M in 2021
Portfolio highlights
- Botify — Search engines miss about half the content on enterprise websites. Uncover those hidden opportunities with Botify, the leading enterprise SEO platform!
- LumApps — LumApps is the only intranet packaged solution that enables employees to feel connected to their organization and engaged in their work from anywhere by delivering a modern, smart digital headquarters that empowers your employees to design a work experience that works for them.
- Stanley Robotics — Stanley Robotics is a DeepTech business helping the transportation and logistics industries digitalise and robotise outdoor operations.
Biotech Investor funding in Sweden at a glance
Stats across 394 deals from 380 investors.
Access all 380 investors in Sweden Biotech startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech Investors in Sweden investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 380 investors investing in Sweden Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!